Facebook Twitter
Print

S41: Evidence-Based Integrative Strategies to Optimize Outcomes for Irritable Bowel Syndrome

15:00 - 16:30, Monroe, Terrace Level

Gerard Mullin (1), Stephen Gurgevich (2), ELizabeth Lipski (3)

(1): Johns Hopkins University School of Medicine, United States      

(2): University of Arizona, United States

(3): Maryland University of Integrative Health, United States

 

 

Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by abdominal pain and altered bowel movements.  The diagnosis of IBS is established by the Rome III criteria. The pathophysiology of IBS involves a complex interplay of factors including hypothalamic-pituitary-adrenal axis dysregulation, heightened perceived stress, visceral hypersensitivity, inflammatory mediators, dietary triggers, gastrointestinal dysbiosis, mast cell activation among others.  This symposium will review the latest advances in research for the use of complementary and alternative medicine (CAM) modalities for IBS.  The program will be organized according to two areas of CAM; mind-body medicine aimed at stress reduction and reduced visceral hyperalgesia and nutritional including diet, herbal and nutraceutical supplements. Mind-body modalities to be presented will include; hypnosis, gut-directed hypnosis, cognitive behavioral therapy, psychotherapy, biofeedback, meditation and acupuncture. Nutritional modalities will include special diets (low FODMAP, lactose-free, wheat-free, elimination diets), herbals (Iberogast, curcumin, Chinese herbals, peppermint oil) and dietary supplements (melatonin, prebiotics, probiotics). Learning objectives include: 1) to become acquainted with the pathophysiology of the irritable bowel syndrome; 2) to know the mind-body modalities that improve outcomes for the irritable bowel syndrome; and 3) to review the special diets, herbal therapies and dietary supplements that have proven efficacy in the irritable bowel syndrome. Gerard Mullin will Introduce the program and objectives,  definitions, epidemiology, economic impact, CAM utilization and pathophysiology of IBS (HPA axis activation, hyperalgesia, neurotransmitters, dysbiosis, mast cell activation, inflammatory mediators, permeability, etc.).  Dr. Gugrevich will present mind-body medicine for IBS, hypnosis, cognitive behavioral therapy,  psychological therapy, acupuncture   meditation-MBSR, and nutritional solutions for IBS.  Dr. Mullin will cover herbals (Iberogast, curcumin, Chinese herbs, peppermint oil), and nutritional supplements (melatonin, prebiotics, probiotics).  Finally, Dr. Elizabeth Lipski, will present on special diets (elimination, lactose-free, low-fructose, FODMAP restricted, gluten-wheat free). The synposia will close with a question and answer session with Drs. Gurgevich, Lipski and Mullin.